CJV-31262-46013
5 vaccinations
9 coded responses
65 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 199 / DE
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Moderna
-
2021-01-23
Registered in v-safe
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
-
2021-02-24
Dose 2 — Moderna
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-26
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-28
Survey response — days 1–6 daily, dose 2MedDRA: Pruritus — Feeling: GoodFree text: Itchy armpit on injection arm two days agoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-11
- 2021-03-18
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-05-27
- 2021-08-25
-
2021-10-22
Dose 3 — Moderna
- 2021-10-22
-
2021-10-23
Survey response — days 1–6 daily, dose 3MedDRA: Apathy — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: General feeling of not wanting to do anythingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Survey response — days 1–6 daily, dose 3MedDRA: Injection site erythema, Injection site warmth — Feeling: Good · Site: Pain, Redness, Swelling · Rash, not including the immediate area around the injection siteFree text: Large red, hot area below the injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Survey response — days 1–6 daily, dose 3MedDRA: Injection site reaction, Rash erythematous, Rash macular — Feeling: Good · Site: Pain, Redness, Itching · Rash, not including the immediate area around the injection siteFree text: Blotchy red rash is on arm below injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Survey response — days 1–6 daily, dose 3MedDRA: Injection site rash — Feeling: Good · Site: Redness · Rash, not including the immediate area around the injection siteFree text: Rash coving large area of arm under injection site, but starting to fadeMedDRA releases: 2024-11 · check-in free text available
- 2021-10-28
- 2021-10-29
- 2021-11-05
- 2021-11-13
- 2021-11-19
- 2021-11-26
- 2021-12-03
-
2022-01-21
Survey response — 3 months, dose 3MedDRA: Breast hyperplasia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Atypical ductal hyperplasia found in breastMedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-25
-
2022-04-23
Survey response — 6 months, dose 3MedDRA: Breast conserving surgery, Intraductal proliferative breast lesion, Invasive ductal breast carcinoma — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Diagnosed with DCIS, a form of pre invasive breast cancer · Healthcare visit (other): LumpectomyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-04-25
-
2022-04-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-04-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-05-03
Dose 4 — Moderna
- 2022-05-03
-
2022-05-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2022-05-05
- 2022-05-06
- 2022-05-07
- 2022-05-08
- 2022-05-09
- 2022-05-10
-
2022-05-17
Survey response — day 14, dose 4MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-05-24
- 2022-05-31
- 2022-06-07
- 2022-06-14
- 2022-08-02
-
2022-09-21
Dose 5 — Moderna
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-10-05
-
2022-10-12
Survey response — day 21, dose 5MedDRA: Head discomfort, Nasal congestion, Rhinorrhoea, Sinusitis — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus infection - stuffy, runny nose, head pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Report sent to call center — day 21, dose 5Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-13
-
2022-10-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-24 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
| 4 | 2022-05-03 | Moderna | No |
| 5 | 2022-09-21 | Moderna | No |
Call center
3 call center cases
3 successful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Itchy armpit on injection arm two days ago
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): General feeling of not wanting to do anything
Systemic reaction (other): Large red, hot area below the injection site
Systemic reaction (other): Blotchy red rash is on arm below injection site
Systemic reaction (other): Rash coving large area of arm under injection site, but starting to fade
Release 11 — 3 months, dose 3
Symptoms: Atypical ductal hyperplasia found in breast
Release 11 — 6 months, dose 3
Symptoms: Diagnosed with DCIS, a form of pre invasive breast cancer
Healthcare visit (other): Lumpectomy
Release 11 — day 14, dose 4
Symptoms: Headache
Release 12 — day 21, dose 5
Symptoms: Sinus infection - stuffy, runny nose, head pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Breast conserving surgery | · | · | ✓ |
| SD | Breast hyperplasia | · | · | ✓ |
| SD | Head discomfort | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Intraductal proliferative breast lesion | · | · | ✓ |
| SD | Invasive ductal breast carcinoma | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Apathy | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site rash | · | · | ✓ |
| SRO | Injection site reaction | · | · | ✓ |
| SRO | Injection site warmth | · | · | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Rash erythematous | · | · | ✓ |
| SRO | Rash macular | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release